Apogee Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
APGE
CUSIP
03770N101
Type
Equity
Class
COM
Num filings
89
Total reported value, excl. options
$1.17 B
Manager Report Date Value ($000) Shares Option Type